Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma i-FABP as Predictor for Irreversible Bowel Ischemia After Interventional Re-vascularization in Patients With Acute Mesenteric Ischemia

NCT01788904 is registered in ClinicalTrials.gov with University Hospital Regensburg as lead sponsor.

NCT NCT01788904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01788904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma i-FABP as Predictor for Irreversible Bowel Ischemia After Interventional Re-vascularization in Patients With Acute Mesenteric Ischemia
Lead sponsor
University Hospital Regensburg
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2013
Completion date
June 30, 2017
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mesenteric ischemia, bowel necrosis